Director
WuXi AppTec
Shanghai, Shanghai, China (People's Republic)
Mr. Jianping Sun is a graduate of the School of Life Sciences at Nanjing University and has been with WuXi AppTec (Shanghai) since 2008. He currently serves as a key leader within the Study Director team of the DMPK Service Department. Mr. Sun possesses five years of laboratory experience in in vitro ADME studies and eleven years of expertise in DMPK project management. He is highly proficient in global IND application strategies for novel drug candidates and has successfully led teams in the completion of over 100 IND application projects. His experience encompasses a wide range of molecular entities, including small molecules, PROTACs, peptides, oligonucleotides, antibodies, and antibody-drug conjugates (ADCs).
Disclosure information not submitted.
Oral Peptide Drug Development: Addressing Preclinical Bioavailability and PK Challenges
Wednesday, November 12, 2025
9:30 AM - 10:00 AM CT